{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:15:34Z","timestamp":1783458934738,"version":"3.55.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111055","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:43:32Z","timestamp":1780292612000},"page":"111055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unveiling the role of single versus repeated low-dose ketamine in attenuating doxorubicin-induced chemobrain and depression in rats: differential modulation of neuroinflammation, phosphorylated GLT-1, SERT, DAT, and BDNF\/TrkB signaling"],"prefix":"10.1016","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6337-7919","authenticated-orcid":false,"given":"Nehal G.","family":"Fahmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2024-3096","authenticated-orcid":false,"given":"Nada M.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3217-5417","authenticated-orcid":false,"given":"Mahmoud M.","family":"Khattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3377-6502","authenticated-orcid":false,"given":"Radwa N.","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111055_bib1","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1007\/s12035-016-0071-4","article-title":"Ketamine exhibits different neuroanatomical profile after Mammalian target of Rapamycin inhibition in the prefrontal cortex: the role of inflammation and oxidative stress","volume":"54","author":"Abelaira","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109313","article-title":"Roles of the monoaminergic system in the antidepressant effects of ketamine and its metabolites","volume":"223","author":"Ago","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111055_bib3","doi-asserted-by":"crossref","first-page":"384","DOI":"10.32007\/jfacmedbagdad.554595","article-title":"Effect of doxorubicin on the histological structure of the kidneys in male albino rats","volume":"55","author":"Al-Hassawi","year":"2013","journal-title":"J. Fac. Med. Baghdad"},{"key":"10.1016\/j.neuropharm.2026.111055_bib4","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.freeradbiomed.2011.03.009","article-title":"2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-\u03b1 release: implications for the reactive oxygen species-mediated mechanisms of chemobrain","volume":"50","author":"Aluise","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2026.111055_bib5","first-page":"441","article-title":"The effect of cancer treatment on cognitive function","volume":"13","author":"Asher","year":"2015","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib6","series-title":"Theory and Practice of Histological Techniques","author":"Bancroft","year":"2008"},{"key":"10.1016\/j.neuropharm.2026.111055_bib7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/bja\/aem218","article-title":"Low-dose ketamine affects immune responses in humans during the early postoperative period","volume":"99","author":"Beilin","year":"2007","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neuropharm.2026.111055_bib8","first-page":"1897","article-title":"A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender","volume":"25","author":"Bergerot","year":"2017","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.neuropharm.2026.111055_bib9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111055_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104736","article-title":"Different mechanisms in doxorubicin-induced neurotoxicity: impact of BRCA mutations","volume":"26","author":"Bhatt","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111055_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tcb.2015.12.002","article-title":"TNF and ROS crosstalk in inflammation","volume":"26","author":"Blaser","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.physbeh.2013.05.012","article-title":"Factors influencing behavior in the forced swim test","volume":"118","author":"Bogdanova","year":"2013","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2026.111055_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/nu9060625","article-title":"Role of Nigella sativa and its constituent thymoquinone on chemotherapy-induced nephrotoxicity: evidences from experimental animal studies","volume":"9","author":"Cascella","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.neuropharm.2026.111055_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2018.07.033","article-title":"Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion","volume":"241","author":"Chen","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2026.111055_bib15","first-page":"1020","volume":"vol. 51","author":"Chen","year":"2018"},{"key":"10.1016\/j.neuropharm.2026.111055_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mpmed.2007.10.012","article-title":"Cytotoxic chemotherapy: clinical aspects","volume":"36","author":"Corrie","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.neuropharm.2026.111055_bib17","doi-asserted-by":"crossref","first-page":"10697","DOI":"10.3390\/ijms130910697","article-title":"Cell signaling through protein kinase C oxidation and activation","volume":"13","author":"Cosentino-Gomes","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111055_bib18","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S2215-0366(19)30292-5","article-title":"US Food and Drug Administration approval of esketamine and brexanolone","volume":"6","author":"Cristea","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111055_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1526-4637.2007.00314.x","article-title":"Side effects of ketamine in the long-term treatment of neuropathic pain","volume":"9","author":"Cvrcek","year":"2008","journal-title":"Pain Med."},{"key":"10.1016\/j.neuropharm.2026.111055_bib20","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1213\/ANE.0b013e3182662e30","article-title":"Does intraoperative ketamine attenuate inflammatory reactivity following surgery? A systematic review and meta-analysis","volume":"115","author":"Dale","year":"2012","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.neuropharm.2026.111055_bib21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/1570159X18666200221113842","article-title":"An overview on chemotherapy-induced cognitive impairment and potential role of antidepressants","volume":"18","author":"Das","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.taap.2012.10.025","article-title":"Development of doxorubicin-induced chronic cardiotoxicity in the B6C3F1 mouse model","volume":"266","author":"Desai","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib23","series-title":"From Molecules to Networks","first-page":"207","article-title":"Pharmacology and biochemistry of synaptic transmission: classical transmitters","author":"Deutch","year":"2014"},{"key":"10.1016\/j.neuropharm.2026.111055_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/srep38771","article-title":"Changes in hippocampal AMPA receptors and cognitive impairments in chronic ketamine addiction models: another understanding of ketamine CNS toxicity","volume":"6","author":"Ding","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111055_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/08860221003611752","article-title":"Thiopental improves renal ischemia-reperfusion injury","volume":"32","author":"Dogan","year":"2010","journal-title":"Ren. Fail."},{"key":"10.1016\/j.neuropharm.2026.111055_bib26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neuropharm.2017.11.022","article-title":"Behavioral and biochemical sensitivity to low doses of ketamine: influence of estrous cycle in C57BL\/6 mice","volume":"130","author":"Dossat","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111055_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.673340","article-title":"Doxorubicin-Induced cognitive impairment: the mechanistic insights","volume":"11","author":"Du","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173078","article-title":"Doxorubicin chemotherapy-induced \"chemo-brain\": Meta-analysis","volume":"881","author":"Eide","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib29","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1007\/s12035-017-0797-7","article-title":"Astaxanthin ameliorates doxorubicin-induced cognitive impairment (Chemobrain) in experimental rat model: impact on oxidative, inflammatory, and apoptotic machineries","volume":"55","author":"El-Agamy","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib30","article-title":"Linking KATP channel activation to p-AKT\/mTORC1\/eEF2\/BDNF axis unravels Nicorandil's promise in countering acetaminophen-induced hepatic encephalopathy in mice","volume":"366\u2013367","author":"Essam","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111055_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2021.113626","article-title":"Ketamine enhances novel object recognition memory reconsolidation via the BDNF\/TrkB pathway in mice","volume":"242","author":"Fan","year":"2021","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2026.111055_bib32","doi-asserted-by":"crossref","first-page":"29702","DOI":"10.1074\/jbc.M112.367706","article-title":"Dopamine transporter phosphorylation site threonine 53 regulates substrate reuptake and amphetamine-stimulated efflux","volume":"287","author":"Foster","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111055_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphys.2024.100117","article-title":"Functional and pathological consequences of being fast on the uptake: protein kinase G and p38\u03b1 MAPK regulation of serotonin transporters","volume":"7","author":"Gajeswski-Kurdziel","year":"2024","journal-title":"Curr Res. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib34","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1742-7843.2008.00210.x","article-title":"Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels","volume":"103","author":"Garcia","year":"2008","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.pnpbp.2009.01.004","article-title":"Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats","volume":"33","author":"Garcia","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111055_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.869792","article-title":"Sex differences in spatial learning and memory in valproic acid rat model of autism: possible beneficial role of exercise interventions","volume":"16","author":"Ghahremani","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111055_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/cells10030518","article-title":"Tumor necrosis factor alpha in amyotrophic lateral sclerosis: friend or foe?","volume":"10","author":"Guidotti","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.111055_bib38","first-page":"61","volume":"vol. 47","author":"Guillem","year":"2022"},{"key":"10.1016\/j.neuropharm.2026.111055_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, glutamate, and glia: a trio of trouble in mood disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111055_bib40","doi-asserted-by":"crossref","first-page":"fcab285","DOI":"10.1093\/braincomms\/fcab285","article-title":"Spike firing attenuation of serotonin neurons in learned helplessness rats is reversed by ketamine","volume":"3","author":"Hashimoto","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.neuropharm.2026.111055_bib41","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2310603","article-title":"Repeated (S)-ketamine administration ameliorates the spatial working memory impairment in mice with chronic pain: role of the gut microbiota-brain axis","volume":"16","author":"Jiang","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.neuropharm.2026.111055_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1124\/jpet.123.001823","article-title":"Ketamine - a new antidepressant drug with anti-inflammatory properties","volume":"388","author":"J\u00f3\u017awiak-B\u0119benista","year":"2024","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111055_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116778","article-title":"Ketamine and nitrous oxide: the evolution of NMDA receptor antagonists as antidepressant agents","volume":"412","author":"Kalmoe","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111055_bib44","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.25718","article-title":"Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (\u201cchemobrain\u201d)","volume":"9","author":"Keeney","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.neuropharm.2026.111055_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109468","article-title":"Chronic oral ketamine prevents anhedonia and alters neuronal activation in the lateral habenula and nucleus accumbens in rats under chronic unpredictable mild stress","volume":"228","author":"Kingir","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111055_bib46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fnbeh.2020.00145","article-title":"To approach or avoid: an introductory overview of the Study of anxiety using rodent assays","volume":"14","author":"La-Vu","year":"2020","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111055_bib47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2199-9-53","article-title":"Selection of reference genes for quantitative real-time PCR in a rat asphyxial cardiac arrest model","volume":"9","author":"Langnaese","year":"2008","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib48","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3389\/fphar.2019.01702","article-title":"Ketamine alleviates postoperative depression-like symptoms in susceptible mice: the role of BDNF-TrkB signaling","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111055_bib49","first-page":"1","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2026.111055_bib50","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2026.111055_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111055_bib52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00210-014-1008-y","article-title":"Quercetin mitigates Adriamycin-induced anxiety-and depression-like behaviors, immune dysfunction, and brain oxidative stress in rats","volume":"387","author":"Merzoug","year":"2014","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuropharm.2026.111055_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainresbull.2011.07.001","article-title":"Epicatechin attenuates doxorubicin-induced brain toxicity: critical role of TNF-\u03b1, iNOS and NF-\u03baB","volume":"86","author":"Mohamed","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2026.111055_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2019.02.005","article-title":"Coping with the forced swim stressor: current state-of-the-art","volume":"364","author":"Molendijk","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111055_bib55","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/s12974-016-0749-6","article-title":"Gene expression comparison reveals distinct basal expression of HOX members and differential TNF-induced response between brain- and spinal cord-derived microvascular endothelial cells","volume":"13","author":"Molino","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111055_bib56","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1042\/BJ20061846","article-title":"Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappab-dependent mechanism","volume":"405","author":"Murillo","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2026.111055_bib57","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00213-025-06803-0","article-title":"(R)-ketamine induces mGlu(5) receptor-dependent antidepressant-like effects in the chronic unpredictable mild stress model of depression in mice","volume":"242","author":"Palucha-Poniewiera","year":"2025","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111055_bib58","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.biopsych.2013.04.027","article-title":"Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats","volume":"74","author":"Parise","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111055_bib59","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuropharm.2018.02.013","article-title":"Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain","volume":"133","author":"Park","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.111055_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105397","article-title":"Ketamine's schizophrenia-like effects are prevented by targeting PTP1B","volume":"155","author":"Qin","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2026.111055_bib61","doi-asserted-by":"crossref","first-page":"11639","DOI":"10.1074\/jbc.M611353200","article-title":"Phosphorylation of threonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP","volume":"282","author":"Ramamoorthy","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2026.111055_bib62","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.bbadis.2019.02.007","article-title":"Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (\u201cchemobrain\u201d), a condition that significantly impairs the quality of life of many cancer survivors","volume":"1865","author":"Ren","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2026.111055_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2021.100422","article-title":"Low-dose S-ketamine exerts antidepressant-like effects via enhanced hippocampal synaptic plasticity in postpartum depression rats","volume":"16","author":"Ren","year":"2022","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.neuropharm.2026.111055_bib64","first-page":"252","volume":"vol. 17","author":"Sayed","year":"2020"},{"key":"10.1016\/j.neuropharm.2026.111055_bib65","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neuropharm.2026.111055_bib66","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3892\/mmr.2012.1147","article-title":"Attenuation of brain edema and spatial learning deficits by the inhibition of NADPH oxidase activity using apocynin following diffuse traumatic brain injury in rats","volume":"7","author":"Song","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.neuropharm.2026.111055_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119527","article-title":"A comprehensive review on time-tested anticancer drug doxorubicin","volume":"278","author":"Sritharan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2026.111055_bib68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2006.02.013","article-title":"Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity","volume":"23","author":"Tangpong","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2026.111055_bib69","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biopsych.2007.02.014","article-title":"Increased response to ketamine following treatment at long intervals: implications for intermittent use","volume":"63","author":"Trujillo","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111055_bib70","first-page":"99","article-title":"Effects of endotoxemia on the pharmacodynamics and pharmacokinetics of ketamine and xylazine anesthesia in Sprague-Dawley rats","volume":"3","author":"Veilleux-Lemieux","year":"2012","journal-title":"Vet Med. (Auckl)"},{"key":"10.1016\/j.neuropharm.2026.111055_bib71","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biopha.2017.09.150","article-title":"Sodium valproate enhances doxorubicin-induced cognitive dysfunction in Wistar rats","volume":"96","author":"Verma","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2026.111055_bib72","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2008.09.001","article-title":"Frequency of climbing behavior as a predictor of altered motor activity in rat forced swimming test","volume":"445","author":"Vieira","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111055_bib73","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2026.111055_bib74","article-title":"Impact of ketamine on learning and memory function, neuronal apoptosis and its potential association with miR-214 and PTEN in adolescent rats","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111055_bib76","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1038\/s41380-020-00865-6","article-title":"Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients","volume":"25","author":"Wang","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111055_bib75","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2014.12.006","article-title":"Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy","volume":"72","author":"Wang","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.neuropharm.2026.111055_bib77","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41392-022-00897-0","article-title":"PKC\u03b1 phosphorylation of GLT-1 at Ser562\/563 induces glutamate excitotoxicity in ischemia in mice","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.neuropharm.2026.111055_bib78","doi-asserted-by":"crossref","first-page":"15480","DOI":"10.1073\/pnas.1512957112","article-title":"Ack1 is a dopamine transporter endocytic brake that rescues a trafficking-dysregulated ADHD coding variant","volume":"112","author":"Wu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111055_bib79","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2015.10.049","article-title":"Role of the NMDA receptor GluN2D subunit in the expression of ketamine-induced behavioral sensitization and region-specific activation of neuronal nitric oxide synthase","volume":"610","author":"Yamamoto","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111055_bib80","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin-independent antidepressant effects of (R)-Ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111055_bib81","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111055_bib82","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2147\/NDT.S502090","article-title":"The impact of esketamine on depression: targeting oxidative stress and neuronal apoptosis through BDNF\/TrkB\/PI3K\/AKT pathway activation","volume":"21","author":"Zhang","year":"2025","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.neuropharm.2026.111055_bib83","first-page":"752","volume":"vol. 11","author":"Zhao","year":"2020"},{"key":"10.1016\/j.neuropharm.2026.111055_bib84","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpsychires.2018.09.013","article-title":"Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression","volume":"106","author":"Zheng","year":"2018","journal-title":"J. Psychiatr. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:35:05Z","timestamp":1783456505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":84,"alternative-id":["S0028390826002297"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111055","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the role of single versus repeated low-dose ketamine in attenuating doxorubicin-induced chemobrain and depression in rats: differential modulation of neuroinflammation, phosphorylated GLT-1, SERT, DAT, and BDNF\/TrkB signaling","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111055"}}